These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges. Liu-Snyder P; Webster TJ Expert Rev Med Devices; 2006 Nov; 3(6):683-7. PubMed ID: 17280531 [No Abstract] [Full Text] [Related]
4. Solid lipid nanoparticles for parenteral drug delivery. Wissing SA; Kayser O; Müller RH Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768 [TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450 [TBL] [Abstract][Full Text] [Related]
7. Advances and challenges of nanotechnology-based drug delivery systems. Jiang W; Kim BY; Rutka JT; Chan WC Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665 [TBL] [Abstract][Full Text] [Related]
9. Drug delivery systems: entering the mainstream. Allen TM; Cullis PR Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496 [TBL] [Abstract][Full Text] [Related]
10. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Haidar ZS; Hamdy RC; Tabrizian M Biotechnol Lett; 2009 Dec; 31(12):1825-35. PubMed ID: 19690811 [TBL] [Abstract][Full Text] [Related]
11. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Silva GA Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859 [TBL] [Abstract][Full Text] [Related]
12. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Gu W; Wu C; Chen J; Xiao Y Int J Nanomedicine; 2013; 8():2305-17. PubMed ID: 23836972 [TBL] [Abstract][Full Text] [Related]
13. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
14. Past and future evolution in colloidal drug delivery systems. Boyd BJ Expert Opin Drug Deliv; 2008 Jan; 5(1):69-85. PubMed ID: 18095929 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for direct nose-to-brain delivery of drugs. Mistry A; Stolnik S; Illum L Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750 [TBL] [Abstract][Full Text] [Related]
16. Nanotechnology and bone healing. Harvey EJ; Henderson JE; Vengallatore ST J Orthop Trauma; 2010 Mar; 24 Suppl 1():S25-30. PubMed ID: 20182231 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge. Santos-Ferreira I; Bettencourt A; Almeida AJ Nanomedicine (Lond); 2015; 10(20):3131-45. PubMed ID: 26446355 [TBL] [Abstract][Full Text] [Related]
18. Nanosystem drug targeting: Facing up to complex realities. Ruenraroengsak P; Cook JM; Florence AT J Control Release; 2010 Feb; 141(3):265-76. PubMed ID: 19895862 [TBL] [Abstract][Full Text] [Related]
19. A review of stimuli-responsive nanocarriers for drug and gene delivery. Ganta S; Devalapally H; Shahiwala A; Amiji M J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822 [TBL] [Abstract][Full Text] [Related]
20. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]